These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 9811463

  • 1. Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer.
    Rieger J, Ständer M, Löschmann PA, Heneka M, Dichgans J, Klockgether T, Weller M.
    Oncogene; 1998 Nov 05; 17(18):2323-32. PubMed ID: 9811463
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
    Naumann U, Durka S, Weller M.
    Oncogene; 1998 Sep 24; 17(12):1567-75. PubMed ID: 9794234
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
    Winter S, Weller M.
    J Pharmacol Exp Ther; 1998 Sep 24; 286(3):1374-82. PubMed ID: 9732400
    [Abstract] [Full Text] [Related]

  • 4. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M.
    Oncogene; 2001 Jul 12; 20(31):4128-37. PubMed ID: 11464279
    [Abstract] [Full Text] [Related]

  • 5. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A.
    J Clin Invest; 1994 Sep 12; 94(3):954-64. PubMed ID: 7521890
    [Abstract] [Full Text] [Related]

  • 6. Fas/APO-1 gene transfer for human malignant glioma.
    Weller M, Malipiero U, Rensing-Ehl A, Barr PJ, Fontana A.
    Cancer Res; 1995 Jul 01; 55(13):2936-44. PubMed ID: 7540953
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
    Darville MI, Eizirik DL.
    Diabetologia; 1998 Sep 01; 41(9):1101-8. PubMed ID: 9754830
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Roles of tyrosine kinases in the regulation of nitric oxide synthesis in murine liver cells: modulation of NF-kappa B activity by tyrosine kinases.
    Lee BS, Kang HS, Pyun KH, Choi I.
    Hepatology; 1997 Apr 01; 25(4):913-9. PubMed ID: 9096597
    [Abstract] [Full Text] [Related]

  • 17. Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions.
    Streffer JR, Schuster M, Pohl U, Belka C, Dichgans J, Bamberg M, Weller M.
    Anticancer Res; 1999 Apr 01; 19(6B):5265-9. PubMed ID: 10697547
    [Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms of TNF-alpha-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and -independent pathways.
    Sawada M, Kiyono T, Nakashima S, Shinoda J, Naganawa T, Hara S, Iwama T, Sakai N.
    Cell Death Differ; 2004 Sep 01; 11(9):997-1008. PubMed ID: 15131591
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.